Expression of IL-6 receptor correlates with Gleason grade for patients with prostatic acinar adenocarcinoma in Kisumu Specialist Hospital in Kisumu County, Western Kenya

Abstract

The potential roles of inflammatory makers in prostate cancer are subjects of intense examination and Interleukin-6 receptor (IL-6R) is key in these processes. Expression of interleukin-6 Receptor (IL-6R) has not been evaluated as a prognostic biomarker in grading of prostate cancer (Pca) in our population, yet inflammation is not uncommon. The current study therefore evaluated their expression in prostatic acinar adeno-carcinoma (PAA) patients of different Gleason grades.